{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:23:11Z","timestamp":1788009791130,"version":"build-2784847793"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nephrol"],"DOI":"10.1007\/s40620-023-01845-z","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T04:03:41Z","timestamp":1704945821000},"page":"1147-1152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Tocilizumab (anti-IL-6) treatment for AA renal amyloidosis in a patient with advanced chronic kidney disease, a case report"],"prefix":"10.1093","volume":"37","author":[{"given":"Charlotte","family":"Seneschall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Roufosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Woodham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0042-1836","authenticated-orcid":false,"given":"Andreas","family":"Kousios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"issue":"2","key":"1845_CR1","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/14397595.2018.1515145","volume":"29","author":"Y Okuda","year":"2019","unstructured":"Okuda Y (2019) AA amyloidosis \u2013 benefits and prospects of IL-6 inhibitors. Mod Rheumatol 29(2):268\u2013274","journal-title":"Mod Rheumatol"},{"key":"1845_CR2","doi-asserted-by":"publisher","first-page":"8493479","DOI":"10.1155\/2022\/8493479","volume":"2022","author":"H Kaaroud","year":"2022","unstructured":"Kaaroud H et al (2022) Renal amyloidosis: epidemiological, clinical, and laboratory profile in adults from one nephrology center. Int J Nephrol 2022:8493479","journal-title":"Int J Nephrol"},{"issue":"6","key":"1845_CR3","doi-asserted-by":"publisher","first-page":"e13966","DOI":"10.1111\/ijcp.13966","volume":"75","author":"S Deshayes","year":"2021","unstructured":"Deshayes S et al (2021) Infections and AA amyloidosis: an overview. Int J Clin Pract 75(6):e13966","journal-title":"Int J Clin Pract"},{"issue":"8","key":"1845_CR4","doi-asserted-by":"publisher","first-page":"100504","DOI":"10.1016\/j.xkme.2022.100504","volume":"4","author":"J Thorne","year":"2022","unstructured":"Thorne J et al (2022) Serum amyloid A protein-associated kidney disease: presentation, diagnosis, and management. Kidney Med 4(8):100504","journal-title":"Kidney Med"},{"issue":"1","key":"1845_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000343398","volume":"37","author":"M Yilmaz","year":"2013","unstructured":"Yilmaz M et al (2013) Renal involvement in AA amyloidosis: clinical outcomes and survival. Kidney and Blood Press Res 37(1):33\u201342","journal-title":"Kidney and Blood Press Res"},{"issue":"1","key":"1845_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cmi.2022.07.008","volume":"29","author":"AM Albuquerque","year":"2022","unstructured":"Albuquerque AM et al (2022) Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis. Clin Microbiol Infect 29(1):13\u201321","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"1845_CR7","first-page":"529","volume":"38","author":"S Sciascia","year":"2020","unstructured":"Sciascia S, Apr\u00e0 F, Baffa A et al (2020) Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. Clin Exp Rheumatol 38(3):529\u2013532","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"1845_CR8","doi-asserted-by":"publisher","first-page":"2997","DOI":"10.1002\/art.22118","volume":"54","author":"Y Okuda","year":"2006","unstructured":"Okuda Y, Takasugi K (2006) Successful use of a humanized anti-interleukin-6 receptor antibody, tocilizumab, to treat amyloid a amyloidosis complicating juvenile idiopathic arthritis. Arthritis Rheum 54(9):2997\u20133000","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1845_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3109\/13506129.2013.838947","volume":"20","author":"A Ho\u010devar","year":"2013","unstructured":"Ho\u010devar A et al (2013) AA amyloidosis in a polyarteritis nodosa patient treated with tocilizumab. Amyloid 20(4):275\u2013276","journal-title":"Amyloid"},{"issue":"3","key":"1845_CR10","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1136\/annrheumdis-2014-206695","volume":"74","author":"S Mori","year":"2015","unstructured":"Mori S et al (2015) Effectiveness and safety of tocilizumab therapy for patients with rheumatoid arthritis and renal insufficiency: a real-life registry study in Japan (the ACTRA-RI study). Ann Rheum Dis 74(3):627","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1845_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s13730-021-00577-y","volume":"10","author":"N Nouri\u00e9","year":"2021","unstructured":"Nouri\u00e9 N et al (2021) Effective treatment with Tocilizumab in a COVID-19 patient on maintenance hemodialysis: a case report. CEN Case Rep 10(3):364\u2013369","journal-title":"CEN Case Rep"},{"issue":"6","key":"1845_CR12","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1111\/cts.12567","volume":"11","author":"M Ovacik","year":"2018","unstructured":"Ovacik M, Lin K (2018) Tutorial on monoclonal antibody pharmacokinetics and its considerations in Early Development. Clin Transl Sci 11(6):540\u2013552","journal-title":"Clin Transl Sci"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-023-01845-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40620-023-01845-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-023-01845-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:53:53Z","timestamp":1777564433000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/37\/4\/1147\/8306744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":12,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["1845"],"URL":"https:\/\/doi.org\/10.1007\/s40620-023-01845-z","relation":{},"ISSN":["1724-6059"],"issn-type":[{"value":"1724-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]},"assertion":[{"value":"9 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from the patient.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}